Burning Rock Biotech Limited BNR
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -2.52M | -2.17M | -2.34M | -1.34M | -1.86M |
| Total Depreciation and Amortization | -- | 3.05M | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | 19.30K | -- | -- | -- |
| Total Other Non-Cash Items | -1.71M | 10.73M | 4.63M | -4.79M | -1.38M |
| Change in Net Operating Assets | -- | -8.38M | -- | -- | -- |
| Cash from Operations | -4.23M | 3.25M | 2.29M | -6.13M | -3.23M |
| Capital Expenditure | -- | -740.40K | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | 121.00K | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -52.60K | 574.30K | -383.80K | 28.60K | -210.50K |
| Cash from Investing | -52.60K | -45.10K | -383.80K | 28.60K | -210.50K |
| Total Debt Issued | -- | 2.00M | -- | -- | -- |
| Total Debt Repaid | -- | -100.00K | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -2.00M | -- | 2.00M | -- |
| Cash from Financing | -- | -14.10K | -- | 276.60K | -- |
| Foreign Exchange rate Adjustments | -388.40K | -1.20M | -236.40K | -33.20K | 41.50K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -4.67M | 1.99M | 1.67M | -5.86M | -3.40M |